2008-10-10 13:08:14 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report analysing the market for nosocomial vaccines.

'Pipeline Insight: Nosocomial Vaccines Minefield or Goldmine?', which is available at www.reportbuyer.com/go/DAT11460 reports that the increasing incidence and severity of nosocomial infections has sparked an interest in preventive strategies such as vaccination.

High costs and reimbursement cuts associated with nosocomial infections provide a strong incentive for healthcare stakeholders to invest in infection prevention, providing a strong

rationale for vaccine development.

The report shows that the increasing spread of resistant strains such as MRSA underlines the urgent need for new strategies for treatment and prevention of these infections.

It further shows that S. aureus is the most frequent pathogen present in the hospital setting in most western countries. In the US alone, an estimated 292,000 hospitalisations with a diagnosis of S. aureus occur each year. The pathogen is by far the most frequent cause of skin and soft tissue infections and affects a wide range of different patient groups. Infections are associated with a longer hospital stay, a poorer clinical outcome and high treatment costs.

With S. aureus emerging as an increasing problem, considerable efforts are being made to reduce infection rates. Hygiene-improvement strategies, such as hand-hygiene programs, thorough disinfection of medical devices and isolation of infected patients have been implemented in many countries.

However, although some success has been achieved with these strategies, their overall impact on infection rates has been limited thus far, and they are unlikely to remain efficacious in the long run, particularly considering the rapid spread of S. aureus in the community setting.

As the reimbursement status for the cost of hospital-acquired infections is under pressure by payors, interest in preventing these complications at the outset is growing. Nosocomial vaccines offer one route of prevention. This report assesses the clinical pipeline candidates, five key nosocomial pathogens and their potential market environment including target population size estimates.

The report 'Pipeline Insight: Nosocomial Vaccines Minefield or Goldmine?' is available from Report Buyer at: www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/pipel ..

Report Buyer product ID: DAT11460

About Report Buyer.

Report Buyer (www.reportbuyer.com/pharma_healthcare/index.html) is a UK-based independent online store supplying business information. The website now carries over 85,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.